Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
activist investor
Biotech
Exelixis dips into the AI game, LIB cashes in on PCSK9
Exelixis is diving into AI drug development in a licensing deal with Insilico, while LIB Therapeutics is cashing in after a second phase 2 victory.
Max Bayer
Sep 12, 2023 11:00am
Testmaker Cue Health under investor pressure to change course
Aug 31, 2023 12:01pm
AIM Immunotech once again battles activist uprising
Aug 29, 2023 10:50am
Nymox faces rebellion led by former execs over stalled deal
Jul 10, 2023 9:05am
Masimo shareholders elect activist investor’s 2 board nominees
Jun 28, 2023 10:29am
Meet Phaxiam: Erytech's merger with Pherecydes is complete
Jun 26, 2023 2:10pm